Serum TNF-a and biomarkers levels after tenofovir therapy in patients with serum HBeAg-positive chronic hepatitis B

QR Code

Serum TNF-a and biomarkers levels after tenofovir therapy in patients with serum HBeAg-positive chronic hepatitis B

Background: Chronic hepatitis B (CHB) remains a wide-spread and serious infectious disease, with its pathogenesis still not fully understood. Tenofovir Amibufenamide, a pro-drug of tenofovir, belongs to the class of nucleoside reverse transcriptase inhibitors and is used in the treatment of CHB. Thi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lai Xijie, Gao Guosheng, Jiang Xiunong
Format:	Article
Language:	English
Published:	Society of Medical Biochemists of Serbia, Belgrade 2025-01-01
Series:	Journal of Medical Biochemistry
Subjects:	chronic hepatitis b tenofovir amibufenamide entecavir liver function renal function tnf-a antiviral efficacy inflammatory markers
Online Access:	https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582503687L.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates
by: Liang Wang, et al.
Published: (2025-07-01)

HBeAg clearance in chronic Hepatitis B: is it predictable?
by: Tuba İlgar, et al.
Published: (2025-06-01)

Monitoring the Effects of Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Switch for Tubulotoxicity in Highly Treatment-Experienced or in Very Sick Individuals Infected with HIV
by: Nicole Marie Lioufas, et al.
Published: (2018-06-01)

Novel Micro-LC-MS/MS Method for the Quantification of Tenofovir and Its Active Metabolite Tenofovir-Diphosphate in Biological Matrices for Therapeutic Drug Monitoring
by: Isabela Tarcomnicu, et al.
Published: (2025-06-01)

Post-liver transplant HBV infection (Review)
by: A. D. Nikogosova, et al.
Published: (2022-07-01)

<i>De novo</i> hepatitis B virus infection after liver transplantation
by: A. D. Nikogosova, et al.
Published: (2022-09-01)

Comparative Efficacy of Etiotropic Therapy of Patients with HBeAg-Positive Chronic Hepatitis B (by the Data of the International Comparative Placebo-Controlled Study)
by: V. V. Stelmakh, et al.
Published: (2020-05-01)

Prevalence and clinical significance of HBeAg-positive chronic hepatitis B patients with and without anti-HBe antibody
by: Ruifei Xue, et al.
Published: (2025-12-01)

HBeAg Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Nucleos(t)ide Analog Treatment: A Systematic Review and Network Meta-Analysis.
by: Tongjing Xing, et al.
Published: (2017-01-01)

Factors predicting renal impairment associated with Tenofovir Disoproxil fumarate: Focus on patients with HIV and pre-existing metabolic abnormalities under the Thai National Health Security Scheme
by: Duangjai Duangrithi, et al.
Published: (2025-08-01)

Efficacy of Tenofovir Disoproxil Fumarate in Preventing Vertical Transmission of Hepatitis B in Mothers with Chronic Hepatitis B: An Evidence-Based Case Report
by: Ris Raihan Felim, et al.
Published: (2024-10-01)

Health Economics Evaluation of Bictegravir/Emtricitabine/Tenofovir for a First-Line Treatment of HIV-1 Infection in China
by: Wang W, et al.
Published: (2025-05-01)

Determination of IFN -γ and TNF -α levels in serum of patients with Cutaneous leishmaniasis
by: Huda M. Taher, et al.
Published: (2020-12-01)

Chronic glomerulonephritis of the mixed type in patient with HBV-infection (<i>Clinical case</i>)
by: V. S. Adonyeva, et al.
Published: (2013-07-01)

Artificial neural network guided optimization of tenofovir and Cyanovirin-N multipurpose preventive hydrogel formulation developed using the Box Behnken design model
by: Karamot O. Oyediran, et al.
Published: (2025-12-01)

Experience of entecavir in renal graft recipients with chronic hepatitis B
by: M. L. Zubkin, et al.
Published: (2011-09-01)

Experience of entecavir therapy in chronic hepatitis B
by: E. V. Esaulenko, et al.
Published: (2014-09-01)

Isolation and identification of some predominant bacteria and assessment of TNF-α level in serum of patients with gingivitis
by: Rahma M. Jaseem, et al.
Published: (2023-10-01)

Anti-HBc IgM associates with acute flare and HBeAg/HBsAg loss in chronic hepatitis B patients with acute exacerbation
by: Ying Zhang, et al.
Published: (2025-12-01)

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
by: Shengxia Yin, et al.
Published: (2023-12-01)

HBsAg clearance and seroconversion case in a patient with HBeAg-negative chronic hepatitis B on pegylated interferon α-2a therapy
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

Levels of Serum Lipid profile and Kidney Function Tests in Iraqi Hypertensive Patients: Duration Effect Study
by: Baghdad Science Journal
Published: (2017-06-01)

Successful viral suppression in a two-year-old child with human immunodeficiency virus infection treated with bictegravir/emtricitabine/tenofovir alafenamide
by: Coskun Ekemen, et al.
Published: (2025-07-01)

High HBsAg clearance rate and viral dynamics in HBeAg-positive, ALT-normal children and adolescents with chronic HBV infection: results from the prospective sprout project
by: Xin Wang, et al.
Published: (2025-12-01)

The relationship between serum irisin levels and renal function in patients with type 2 diabetes mellitus
by: Robab Beigom Aboutorabi, et al.
Published: (2025-06-01)

Evaluation of serum brain-derived neurotrophic factor, IL-6, IL-10, and TNF-a cognitive function, and sleep quality in elderly patients with major depressive disorder and somatic symptoms
by: Gao Ya, et al.
Published: (2025-01-01)

Development and validation of the methods for determination of tenophovir in the blood plasma of rabbits
by: Yu. V. Medvedev, et al.
Published: (2011-09-01)

Nomogram for evaluating obvious liver inflammation in treatment-naïve HBeAg positive chronic hepatitis B virus infection patients with normal ALT
by: Lu Zhang, et al.
Published: (2023-12-01)

Methylprednisolone effects on serum biochemical factors (CRP, PCT, IL-6, TNF-a) in viral pneumonia
by: Zeng Hongping, et al.
Published: (2025-01-01)

BIOLOGICAL EFFECTS OF TNF-BINDING VARIOLAVIRUS RECOMBINANT PROTEIN
by: I. A. Orlovskaya, et al.
Published: (2014-07-01)

Rapid suppression of HBV replication before related liver transplantation in a patient with HDV superinfection. Clinical case report
by: U. R. Salimov, et al.
Published: (2024-09-01)

HBV-INFECTION DE NOVO AFTER ORTHOTOPIC LIVER TRANSPLANTATION: CLINICAL AND VIROLOGICAL CHARACTERISTICS, ASSESSMENT OF ANTIVIRUS THERAPY EFFECTIVENESS
by: O. I. Malomuzh, et al.
Published: (2012-09-01)

Proteomics of Urinary Extracellular Vesicles Highlight the Involvement of Vitronectin and the Fibrinolytic and TNF Pathways as Mechanisms Underlying Renal Fibrosis in Kidney Transplant Patients
by: Marta Clos‐Sansalvador, et al.
Published: (2025-06-01)

Serum IL-6, IL-10, TNF-a changes in postpartum perineal oedema rehabilitation
by: Xue Lili, et al.
Published: (2025-01-01)

Reproductive effects of the tumor necrosis factor (TNF) deficiency in mice
by: S. O. Maslennikova, et al.
Published: (2015-12-01)

The Role of IL-6 and TNF-α as Early Biomarkers in the Prediction and Diagnosis of Gestational Diabetes Mellitus
by: Antonia Varthaliti, et al.
Published: (2025-07-01)

Serum Erythropoietin in Patients with Chronic Renal Failure in the Predialysis Stage
by: Adelaida Ruseva, et al.
Published: (2023-12-01)

The role of TNF-? in the pathogenesis of multiple myeloma “a study in Iraqi patients”
by: Baghdad Science Journal
Published: (2014-06-01)

From genotype to protein: how the 308 G/A polymorphism of the TNF-α gene is associated with TNF-α protein levels in patients with Hashimoto’s thyroiditis
by: R. R. Rahimova, et al.
Published: (2025-06-01)

Tissue inflammation induced by constitutively active STING is mediated by enhanced TNF signaling
by: Hella Luksch, et al.
Published: (2025-03-01)